EUVIMEDEUVIMED entdecken
Crossref

Mycoplasma infection of cancer cells enhances anti-tumor effect of oxidized methylcytidines

Guo-Zheng Pang, Ya-Hui Zhao, Yuan-Xian Wang, Shao-Qin Rong, Hai Gao, Dan Zhou

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.06.052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Guo-Zheng Pang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan Univers…. Hauptthemen laut MEDLINE: Neoplasms, Mycoplasma Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Chinese Academy of Meteorological Sciences, Postdoctoral Research Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidized methylcytidines 5-hydroxymethyl-2'deoxycytidine (5hmdC) and 5-formy-2'deoxycytidine (5fdC) are deaminated by cytidine deaminase (CDA) into genome-toxic variants of uridine, triggering DNA damage and cell death. These compounds are promising chemotherapeutic agents for cancer cells that are resistant to pyrimidine derivative drugs, such as decitabine and cytarabine, which are inactivated by CDA. In our study, we found that cancer cells infected with mycoplasma exhibited a markedly increased sensitivity to 5hmdC and 5fdC, which was independent of CDA expression of cancer cells. In vitro biochemical assay showed that the homologous CDA protein from mycoplasma was capable of deaminating 5hmdC and 5fdC into their uridine form. Moreover, mycoplasma infection increased the sensitivity of cancer cells to 5hmdC and 5fdC, whereas administration of Tetrahydrouridine (THU) attenuated this effect, suggesting that mycoplasma CDA confers a similar effect as human CDA. As mycoplasma infection occurs in many primary tumors, our findings suggest that intratumoral microbes could enhance the tumor-killing effect and expand the utility of oxidized methylcytidines in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMycoplasma InfectionsHumansUridineTetrahydrouridineCytidine DeaminaseDeoxycytidine

Stichwörter der Autor:innen

5fdC5hmdCCytidine deaminaseIntratumoral microbesMycoplasma

Substanzen

UridineTetrahydrouridineCytidine DeaminaseDeoxycytidine

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai, 200032, Ch…
  • Center for Novel Target and Therapeutic Intervention, Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China.

Förderung

  • China Postdoctoral Science Foundation
  • Chinese Academy of Meteorological Sciences
  • Postdoctoral Research Foundation of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai

Zitieren

APA

Pang, G. Z., Zhao, Y. H., Wang, Y. X., Rong, S. Q., Gao, H., & Zhou, D. (2023). Mycoplasma infection of cancer cells enhances anti-tumor effect of oxidized methylcytidines. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.06.052

Vancouver

Pang GZ, Zhao YH, Wang YX, Rong SQ, Gao H, Zhou D. Mycoplasma infection of cancer cells enhances anti-tumor effect of oxidized methylcytidines. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.06.052

BibTeX
@article{Pang2023,
  author = {Pang, Guo-Zheng and Zhao, Ya-Hui and Wang, Yuan-Xian and Rong, Shao-Qin and Gao, Hai and Zhou, Dan},
  title = {Mycoplasma infection of cancer cells enhances anti-tumor effect of oxidized methylcytidines},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.06.052}
}
Kostenlos starten →